Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.

Donadello K, Scolletta S, Taccone FS, Covajes C, Santonocito C, Cortes DO, Grazulyte D, Gottin L, Vincent JL.

J Crit Care. 2014 Feb;29(1):144-9. doi: 10.1016/j.jcrc.2013.08.005. Epub 2013 Oct 9.

PMID:
24120089
[PubMed - indexed for MEDLINE]
2.

Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?

Udy AA, Covajes C, Taccone FS, Jacobs F, Vincent JL, Lipman J, Roberts JA.

Int J Antimicrob Agents. 2013 Jun;41(6):564-8. doi: 10.1016/j.ijantimicag.2013.01.018. Epub 2013 Mar 6.

PMID:
23473944
[PubMed - indexed for MEDLINE]
3.

Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy.

Covajes C, Scolletta S, Penaccini L, Ocampos-Martinez E, Abdelhadii A, Beumier M, Jacobs F, de Backer D, Vincent JL, Taccone FS.

Int J Antimicrob Agents. 2013 Mar;41(3):261-6. doi: 10.1016/j.ijantimicag.2012.10.018. Epub 2013 Jan 9.

PMID:
23312601
[PubMed - indexed for MEDLINE]
4.

suPAR as a prognostic biomarker in sepsis.

Donadello K, Scolletta S, Covajes C, Vincent JL.

BMC Med. 2012 Jan 5;10:2. doi: 10.1186/1741-7015-10-2. Review.

PMID:
22221662
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk